期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Improvedendoscopicretrogradecholangiopancreatographybrushincreases diagnosticyieldofmalignantbiliarystrictures 被引量:5
1
作者 Shieh fK Luong-Player A +5 位作者 Khara HS Liu H lin f Shellenberger MJ Johal AS Diehl DL 《World Journal of Gastrointestinal Endoscopy》 2014年第7期312-317,共6页
AIM: To determine if a new brush design could im-prove the diagnostic yield of biliary stricture brushings. METHODS: Retrospective chart review was performed of all endoscopic retrograde cholangiopancreatography proce... AIM: To determine if a new brush design could im-prove the diagnostic yield of biliary stricture brushings. METHODS: Retrospective chart review was performed of all endoscopic retrograde cholangiopancreatography procedures with malignant biliary stricture brushing between January 2008 and October 2012. A standard wire-guided cytology brush was used prior to proto-col implementation in July 2011, after which, a new 9 French wire-guided cytology brush(Infinity sampling device, US Endoscopy, Mentor, OH) was used for all cases. All specimens were reviewed by blinded pa-thologists who determined whether the sample waspositive or negative for malignancy. Cellular yield was quantified by describing the number of cell clusters seen. RESULTS: Thirty-two new brush cases were compared to 46 historical controls. Twenty-five of 32 (78%) cases in the new brush group showed abnormal cellular find-ings consistent with malignancy as compared to 17 of 46(37%) in the historical control group(P = 0.0003). There was also a significant increase in the average number of cell clusters of all sizes(21.1 vs 9.9 clusters, P = 0.0007) in the new brush group compared to his-torical controls. CONCLUSION: The use of a new brush design for brush cytology of biliary strictures shows increased di-agnostic accuracy, likely due to improved cellular yield, as evidenced by an increase in number of cellular clus-ters obtained. 展开更多
关键词 Malignant biliary stricture Endoscopic ret-rograde cholangiopancreatography Brush cytology Diagnostic yield CYTOPATHOLOGY
暂未订购
肝内胆管细胞癌和转移性胰腺导管腺癌的免疫组化鉴别 被引量:4
2
作者 Lok T Chen L +2 位作者 lin f 王慧 余英豪 《临床与实验病理学杂志》 CAS CSCD 北大核心 2014年第10期1116-1116,共1页
在肝脏活检标本中,原发性肝内胆管细胞癌(ICC)和转移性胰腺导管腺癌(PDA)组织学上难以区分,但二者的鉴别具有重要的临床意义。本组实验对41例ICCs和60例PDAs分别进行SLOOP、pVHL、IMP3、肿瘤抑制基因蛋白maspin、MUC5AC及CKl7蛋... 在肝脏活检标本中,原发性肝内胆管细胞癌(ICC)和转移性胰腺导管腺癌(PDA)组织学上难以区分,但二者的鉴别具有重要的临床意义。本组实验对41例ICCs和60例PDAs分别进行SLOOP、pVHL、IMP3、肿瘤抑制基因蛋白maspin、MUC5AC及CKl7蛋白的免疫表型评估,以了解这些标志物在两种疾病鉴别诊断中的价值。结果显示:29例(71%)ICCs表达pVHL,PDAs中仅3例(5%)出现pVHL表达。S100P、MUC5AC和CKl7在PDAs中阳性率较高,分别为57例(95%)、40例(67%)和36例(60%),ICCs中S100P、MUC5AC和CK17分别为11例(27%)、5例(12%)及5例(12%)表达。IMP3在ICCs和PDAs中阳性率均为90%。60例(100%)PDA和30例(73%)ICC患者存在maspin的阳性表达。作者对上述标志物表达情况进行归纳后发现,当免疫组化染色结果呈SLOOP-/pVHL+/MUC5AC-/CK17-时提示ICC,呈SLOOP+/pVHL-/MUC5AC+/CK17+和S100P+/pVHL-/MUC5AC-/CK17+时则提示PDA。据此可有效将ICC和PDA鉴别开来。 展开更多
关键词 原发性肝内胆管细胞癌 胰腺导管腺癌 免疫组化 化鉴别 转移性 MUC5AC MASPIN ICCs
暂未订购
一种可用于诊断肾细胞癌和卵巢透明细胞癌的免疫组化标记物人肾损伤分子-1(英)
3
作者 lin f 吴继华(译) 张建中(校) 《诊断病理学杂志》 CSCD 2008年第2期148-148,共1页
关键词 转移性肾细胞癌 卵巢透明细胞癌 损伤分子 免疫组化 诊断 标记物 肾细胞肿瘤 嗜酸细胞腺瘤
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部